Aditi Bhattacharya - Publications

Affiliations: 
National Centre for Biological Sciences, Bengaluru, Karnataka, India 
Area:
Serotonin Receptor signaling and trafficking

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bowling HL, Kasper A, Patole C, Venkatasubramani JP, Leventer SP, Carmody E, Sharp K, Berry-Kravis E, Kirshenbaum K, Klann E, Bhattacharya A. Optimization of protocols for detection of de novo protein synthesis in whole blood samples via azide-alkyne cycloaddition. Journal of Proteome Research. PMID 32786687 DOI: 10.1021/Acs.Jproteome.0C00299  0.747
2020 Jasoliya M, Bowling H, Petrasic IC, Durbin-Johnson B, Klann E, Bhattacharya A, Hagerman R, Tassone F. Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome. Brain Sciences. 10. PMID 32531912 DOI: 10.3390/Brainsci10060361  0.75
2020 Ghosh Dastidar S, Das Sharma S, Chakraborty S, Chattarji S, Bhattacharya A, Muddashetty RS. Distinct regulation of bioenergetics and translation by group I mGluR and NMDAR. Embo Reports. e48037. PMID 32351028 DOI: 10.15252/embr.201948037  0.325
2020 Priya Venkatasubramani J, Subramanyam P, Pal R, Reddy BK, Jeyalakshmi Srinivasan D, Chattarji S, Iossifov I, Klann E, Bhattacharya A. N-terminal variant Asp14 Asn of the human p70 S6 Kinase 1 enhances translational signaling causing different effects in developing and mature neuronal cells. Neurobiology of Learning and Memory. 107203. PMID 32147585 DOI: 10.1016/j.nlm.2020.107203  0.55
2019 Bowling H, Bhattacharya A, Zhang G, Alam D, Lebowitz JZ, Bohm-Levine N, Lin D, Singha P, Mamcarz M, Puckett R, Zhou L, Aryal S, Sharp K, Kirshenbaum K, Berry-Kravis E, et al. Altered steady state and activity-dependent de novo protein expression in fragile X syndrome. Nature Communications. 10: 1710. PMID 30979884 DOI: 10.1038/S41467-019-09553-8  0.753
2019 Soman S, Bhattacharya A, Panicker MM. Dopamine Requires Unique Residues to Signal via the Serotonin 2A Receptor. Neuroscience. PMID 30970266 DOI: 10.1016/J.Neuroscience.2019.03.056  0.644
2016 Bowling H, Bhattacharya A, Klann E, Chao MV. Deconstructing brain-derived neurotrophic factor actions in adult brain circuits to bridge an existing informational gap in neuro-cell biology. Neural Regeneration Research. 11: 363-7. PMID 27127458 DOI: 10.4103/1673-5374.179031  0.76
2015 Bhattacharya A, Mamcarz M, Mullins C, Choudhury A, Boyle RG, Smith DG, Walker DW, Klann E. Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26708105 DOI: 10.1038/npp.2015.369  0.618
2015 Bowling H, Bhattacharya A, Zhang G, Lebowitz JZ, Alam D, Smith PT, Kirshenbaum K, Neubert TA, Vogel C, Chao MV, Klann E. BONLAC: A Combinatorial Proteomic Technique to Measure Stimulus-induced Translational Profiles in Brain Slices. Neuropharmacology. PMID 26205778 DOI: 10.1016/J.Neuropharm.2015.07.017  0.751
2015 Gross C, Chang CW, Kelly SM, Bhattacharya A, McBride SM, Danielson SW, Jiang MQ, Chan CB, Ye K, Gibson JR, Klann E, Jongens TA, Moberg KH, Huber KM, Bassell GJ. Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome. Cell Reports. 11: 727-36. PMID 25921541 DOI: 10.1016/J.Celrep.2015.03.060  0.65
2014 Kumari D, Bhattacharya A, Nadel J, Moulton K, Zeak NM, Glicksman A, Dobkin C, Brick DJ, Schwartz PH, Smith CB, Klann E, Usdin K. Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs. Human Mutation. 35: 1485-94. PMID 25224527 DOI: 10.1002/humu.22699  0.616
2014 Trinh MA, Ma T, Kaphzan H, Bhattacharya A, Antion MD, Cavener DR, Hoeffer CA, Klann E. The eIF2α kinase PERK limits the expression of hippocampal metabotropic glutamate receptor-dependent long-term depression. Learning & Memory (Cold Spring Harbor, N.Y.). 21: 298-304. PMID 24741110 DOI: 10.1101/Lm.032219.113  0.655
2014 Bowling H, Zhang G, Bhattacharya A, Pérez-Cuesta LM, Deinhardt K, Hoeffer CA, Neubert TA, Gan WB, Klann E, Chao MV. Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity. Science Signaling. 7: ra4. PMID 24425786 DOI: 10.1126/Scisignal.2004331  0.774
2014 Bhattacharya A, Klann E. (Li+)ghting the way for a treatment for cognitive impairments in fragile X syndrome. Biological Psychiatry. 75: 175-6. PMID 24370350 DOI: 10.1016/j.biopsych.2013.11.017  0.598
2012 Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron. 76: 325-37. PMID 23083736 DOI: 10.1016/J.Neuron.2012.07.022  0.638
2012 Bhattacharya A, Klann E. The molecular basis of cognitive deficits in pervasive developmental disorders. Learning & Memory (Cold Spring Harbor, N.Y.). 19: 434-43. PMID 22904374 DOI: 10.1101/lm.025007.111  0.524
2012 Bhattacharya A, Klann E. Fragile X syndrome therapeutics S(C)TEP through the developmental window. Neuron. 74: 1-3. PMID 22500622 DOI: 10.1016/j.neuron.2012.03.014  0.541
2012 Chévere-Torres I, Kaphzan H, Bhattacharya A, Kang A, Maki JM, Gambello MJ, Arbiser JL, Santini E, Klann E. Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex. Neurobiology of Disease. 45: 1101-10. PMID 22198573 DOI: 10.1016/J.Nbd.2011.12.028  0.73
2010 Bhattacharya A, Sankar S, Panicker MM. Differences in the C-terminus contribute to variations in trafficking between rat and human 5-HT(2A) receptor isoforms: identification of a primate-specific tripeptide ASK motif that confers GRK-2 and beta arrestin-2 interactions. Journal of Neurochemistry. 112: 723-32. PMID 19919577 DOI: 10.1111/J.1471-4159.2009.06493.X  0.644
2009 Kanagarajadurai K, Malini M, Bhattacharya A, Panicker MM, Sowdhamini R. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding. Molecular Biosystems. 5: 1877-88. PMID 19763327 DOI: 10.1039/B906391A  0.643
2006 Bhattacharyya S, Raote I, Bhattacharya A, Miledi R, Panicker MM. Activation, internalization, and recycling of the serotonin 2A receptor by dopamine. Proceedings of the National Academy of Sciences of the United States of America. 103: 15248-53. PMID 17005723 DOI: 10.1073/Pnas.0606578103  0.721
Show low-probability matches.